Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

Alcohol consumption poses a significant global health risk, contributing to numerous diseases and injuries, especially among ...

Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the clinical trial involving 800 participants, in which a weekly dose of semaglutide ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Measles cases in the United States climbed to 939 in 29 states, the Centers for Disease Control and Prevention said Friday.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

A decision is expected in the fourth quarter of 2025.

Decades of research have turned up no miracle treatment for measles, but studies show the M.M.R. shot is 97 percent effective ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Altimmune shares jumped 8.5% on Friday. The stock is higher ahead of next week's presentation at the European Association for ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...